Roche Offers $5.7 Billion for Illumina, Jan. 25

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Jan. 25 (Bloomberg) -- Roche Holding AG, the world’s biggest cancer-drug maker, offered about $5.7 billion in cash for Illumina Inc. in a hostile bid to bolster research in the biomarkers of diseases that will yield better targeted therapies. Mark Barton and Caroline Hyde report on Bloomberg Television's "First Look." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change